サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654304

豚ワクチンの世界市場：市場規模・シェア・動向分析 (製品別・種類別・投与経路別・地域別)、セグメント別予測 (2025年～2030年)

Swine Vaccines Market Size, Share & Trends Analysis Report By Product (Inactivated, Modified/Attenuated Live), By Type (Pseudorabies, Porcine Circovirus Type 2), By Route Of Administration, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
豚ワクチンの世界市場：市場規模・シェア・動向分析 (製品別・種類別・投与経路別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年01月23日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

豚ワクチン市場の成長と動向：

Grand View Research社の最新レポートによると、豚用ワクチンの世界市場規模は2030年までに24億1,000万米ドルに達する見込みです。

この市場は、2025年から2030年までのCAGRが5.51%となる見込みです。豚疾病の蔓延と発生率の増加、人獣共通感染症に対する懸念の高まり、養豚場間のバイオセキュリティ対策の強化は、市場成長を増大させる主な要因の一部です。加えて、政府および動物医療団体による、病気に対する認識を広め、ワクチン接種を支援する取り組みが、予測期間中の市場成長をさらに後押ししています。

COVID-19パンデミックは、主要企業の豚ワクチン事業運営に直接的または間接的な影響を与え、当初は業績が悪化しました。パンデミックによる様々な生産とサプライチェーンのボトルネックの影響により、必要な原材料や有効成分の供給が遅れ、研究開発活動の一部が延期されました。しかし、いくつかの地域で同時に報告されたアフリカ豚熱の発生は、豚ワクチンメーカーに大きな需要を迫った。2020年、OIEはアジアで9,928件、次いで欧州で4,271件のASF発生を報告しました。したがって、このような状況を考慮し、政府は豚ワクチンの流通を規制緩和で支援しました。

加えて、抗生物質耐性に関する世界の懸念は、農業や獣医学で高まっています。そのため、いくつかの国では、予防的治療処置も含め、畜産における抗生物質の使用を禁止しています。この法律により、養豚場はワクチン接種のような抗生物質を使用しない疾病予防アプローチを採用せざるを得なくなっています。さらに、より良い診断のための先進的な製品を開発するための主要企業による投資の発展が、市場開拓を促進すると思われます。例えば、2020年5月、Indian Immunologicals Ltd.は、インド獣医研究所 (Bareilly) と共同で開発した独自の細胞培養技術に基づくワクチン「Raksha Class」のブランド名で古典的豚熱ワクチンを発表しました。

市場の主要企業は、市場での競争力を維持するため、企業合併・買収 (M&A)、提携、製品発売など、さまざまな戦略的取り組みを実施しています。例えば、2022年3月、Ceva社は、新生児下痢症の治療に使用される7つの抗原を含むワクチンである種豚用ワクチンを発売しました。

豚ワクチン市場：分析概要

  • 不活化 (死菌) ワクチンは、2024年に52.03%の最大売上シェアで市場をリードしました。これは、入手のしやすさ、コストの低さ、安定性など、生ワクチンに比べて優れていることによる。
  • 疾患の種類別では、PRRS (豚繁殖・呼吸障害症候群) が2024年に14.26%の最大売上シェアで市場をリードしました。
  • 投与経路別では、豚の主な疾病に対する長期的な防御を提供する効率性と有効性により、注射剤が2024年に75.79%の最大収益シェアで市場をリードしました。
  • 流通チャネル別では、病院/クリニック薬局が2024年に最大の売上シェアを占めました。これは、エンドユーザーとの直接的な関わり、即時のワクチン接種サービス、包括的な医療ソリューションにより、タイムリーなワクチン配布と畜産部門における効果的な疾病管理が確保されているためです。
  • 2024年の豚ワクチン市場は、北米が38.46%の最大売上シェアを占めました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 豚ワクチン市場：変動要因・傾向・範囲

  • 市場連関の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 豚ワクチン市場：分析ツール
  • ビジネス環境分析
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析
    • 政治情勢
    • 製品パイプライン分析
    • COVID-19分析
    • 豚の推定飼育頭数：主要国別 (2018～2024年)

第4章 豚ワクチン市場：製品別のビジネス分析

  • 市場シェア：製品別 (2024年・2030年)
  • 製品別ダッシュボード
  • 市場規模の予測と動向分析：製品別 (2018～2030年)
  • 修正/減衰生
  • 不活化 (死菌)
  • その他

第5章 豚ワクチン市場：疾患の種類別のビジネス分析

  • 市場シェア：疾患の種類別 (2024年・2030年)
  • 疾患の種類別ダッシュボード
  • 市場規模の予測と動向分析：疾患の種類別 (2018～2030年)
  • 豚インフルエンザ
  • 豚コレラ
  • 豚パルボウイルス
  • 豚サーコウイルス2型
  • M.Hyo
  • アクチノバチルス肺炎
  • 抗レトロウイルス薬
  • 口蹄疫
  • 仮性狂犬病
  • PEDV

第6章 豚ワクチン市場：投与経路別のビジネス分析

  • 市場シェア：投与経路別 (2024年・2030年)
  • 投与経路別ダッシュボード
  • 市場規模の予測と動向分析：投与経路別 (2018～2030年)
  • 注射剤
  • 経鼻剤
  • 経口剤

第7章 豚ワクチン市場：流通チャネル別のビジネス分析

  • 市場シェア：流通チャネル別 (2024年・2030年)
  • 流通チャネル別ダッシュボード
  • 市場規模の予測と動向分析：流通チャネル別 (2018～2030年)
  • 小売り
  • eコマース
  • 病院・クリニック薬局

第8章 豚ワクチン市場：地域別の推定と動向分析 (製品別・疾患の種類別・投与経路別・流通チャネル別)

  • 市場シェア：地域別 (2024年・2030年)
  • 地域別の市場ダッシュボード
  • 市場規模の予測と動向分析：地域別 (2018～2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ

第9章 競合情勢

  • 参入企業の概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Merck &Co., Inc.
    • Ceva
    • Zoetis
    • Boehringer Ingelheim GmbH
    • Elanco
    • Indian Immunologicals Ltd.
    • BiogenesisBago
    • Phibro Animal Health
    • KM Biologics
    • HIPRA
    • Virbac

第10章 重要なポイント

図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Global Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 5 Global Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 6 Global Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 7 Global Swine Vaccines Market, By Region, 2018 - 2030 (USD Million)
  • Table 8 North America Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 11 North America Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 North America Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 U.S. Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 16 U.S. Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Canada Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 20 Canada Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Mexico Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 Mexico Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 23 Mexico Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 24 Mexico Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 Europe Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Europe Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 28 Europe Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 29 Europe Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 Germany Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Germany Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 32 Germany Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 Germany Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 UK Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 UK Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 36 UK Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 UK Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 France Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 France Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 40 France Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 41 France Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Italy Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 43 Italy Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 44 Italy Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 45 Italy Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Spain Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Spain Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 48 Spain Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 49 Spain Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Denmark Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Denmark Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 52 Denmark Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 Denmark Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Sweden Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 Sweden Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 56 Sweden Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 57 Sweden Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Norway Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 59 Norway Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 60 Norway Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 61 Norway Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 China Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 China Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 69 China Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 70 China Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 Japan Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 73 Japan Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 India Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 76 India Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 77 India Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 India Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 South Korea Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 81 South Korea Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 South Korea Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Australia Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 85 Australia Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 86 Australia Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Thailand Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 89 Thailand Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 90 Thailand Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 Latin America Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 93 Latin America Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 94 Latin America Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 95 Latin America Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 Brazil Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Brazil Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 98 Brazil Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 99 Brazil Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 100 Argentina Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 101 Argentina Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 102 Argentina Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 103 Argentina Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Swine Vaccines Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 South Africa Swine Vaccines Market, By Product, 2018 - 2030 (USD Million)
  • Table 110 South Africa Swine Vaccines Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 111 South Africa Swine Vaccines Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 112 South Africa Swine Vaccines Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Swine Vaccines Market, Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Swine Vaccines Market, for Product, 2018 - 2030 (USD Million)
  • Fig. 15 Global Swine Vaccines Market, for Modified/Attenuated Live, 2018 - 2030 (USD Million)
  • Fig. 16 Global Swine Vaccines Market, for Inactivated (Killed), 2018 - 2030 (USD Million)
  • Fig. 17 Global Swine Vaccines Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 18 Global Swine Vaccines Market, for Disease Type, 2018 - 2030 (USD Million)
  • Fig. 19 Global Swine Vaccines Market, for Swine Influenza, 2018 - 2030 (USD Million)
  • Fig. 20 Global Swine Vaccines Market, for Classical Swine Fever, 2018 - 2030 (USD Million)
  • Fig. 21 Global Swine Vaccines Market, for Porcine Parvovirus, 2018 - 2030 (USD Million)
  • Fig. 22 Global Swine Vaccines Market, for Porcine Circovirus Type 2, 2018 - 2030 (USD Million)
  • Fig. 23 Global Swine Vaccines Market, for M.Hyo, 2018 - 2030 (USD Million)
  • Fig. 24 Global Swine Vaccines Market, for Actinobacillus Pleuropneumonia, 2018 - 2030 (USD Million)
  • Fig. 25 Global Swine Vaccines Market, for PRRS, 2018 - 2030 (USD Million)
  • Fig. 26 Global Swine Vaccines Market, for Foot & Mouth Disease, 2018 - 2030 (USD Million)
  • Fig. 27 Global Swine Vaccines Market, for Pseudorabies, 2018 - 2030 (USD Million)
  • Fig. 28 Global Swine Vaccines Market, for PEDV, 2018 - 2030 (USD Million)
  • Fig. 29 Global Swine Vaccines Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Global Swine Vaccines Market, for Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 31 Global Swine Vaccines Market, for Injectables, 2018 - 2030 (USD Million)
  • Fig. 32 Global Swine Vaccines Market, for Intranasal, 2018 - 2030 (USD Million)
  • Fig. 33 Global Swine Vaccines Market, for Oral, 2018 - 2030 (USD Million)
  • Fig. 34 Global Swine Vaccines Market, for Distribution Channel, 2018 - 2030 (USD Million)
  • Fig. 35 Global Swine Vaccines Market, for Retail, 2018 - 2030 (USD Million)
  • Fig. 36 Global Swine Vaccines Market, for E-Commerce, 2018 - 2030 (USD Million)
  • Fig. 37 Global Swine Vaccines Market, for Hospital/Clinic Pharmacies, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Outlook, 2024 & 2030
  • Fig. 39 North America Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 45 UK Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 46 France Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 48 Spain Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 50 Sweden Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 55 India Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 58 Thailand Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 59 Latin America Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 60 Brazil Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East and Africa Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Swine Vaccines Market, 2018 - 2030 (USD Million)
  • Fig. 64 Company categorization
  • Fig. 65 Company market position analysis
  • Fig. 66 Strategic framework
目次
Product Code: GVR-4-68039-728-0

Swine Vaccines Market Growth & Trends:

The global swine vaccines market size is expected to reach USD 2.41 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness a lucrative CAGR of 5.51% from 2025 to 2030. The increasing prevalence and incidence of swine diseases, rising concerns over zoonoses, and strengthening biosecurity measures among swine farms are some of the major factors augmenting the market growth. In addition, the initiatives taken by government and animal healthcare organizations in spreading disease awareness and supporting vaccination drives are further propelling the market growth during the projected period.

The Covid-19 pandemic has directly or indirectly impacted the key player's swine vaccine business operations and resulted in declined financial performance during the initial time. The effect of the pandemic with various production and supply chain bottlenecks delayed the delivery of necessary raw materials or active ingredients and postponed certain research & development activities. However, the simultaneously reported African swine fever outbreaks in several regions pressured the swine vaccine manufacturers with a large demand. In 2020, the OIE reported 9,928 ASF outbreaks in Asia, followed by 4,271 outbreaks in Europe. Hence, considering the situation, the government supported the distribution of swine vaccines with ease of restrictions, which afforded opportunities to rebuild the company's growth.

In addition, the global concern regarding antibiotic resistance is growing in agriculture and veterinary medicine. Thus, several countries have banned the use of antibiotics for livestock farming, including preventive treatment procedures. This act has compelled swine farms to adopt antibiotic-free disease preventive approaches such as vaccination. Furthermore, growing investments by key players to develop advanced products for better diagnosis are likely to propel market growth. For instance, in May 2020, Indian Immunologicals Ltd. introduced the Classical Swine Fever vaccine under the brand name 'Raksha Class', a unique cell culture technology-based vaccine developed in cooperation with the Indian Veterinary Research Institute, Bareilly.

Key players in the market are implementing various strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, among others to maintain a competitive edge in the market. For instance, In March 2022, Ceva launched the sow vaccine, a vaccine containing seven antigens used to treat neonatal diarrhea.

Swine Vaccines Market Report Highlights:

  • The Inactivated (Killed) segment led the market with the largest revenue share of 52.03% in 2024. This is attributed to its easy availability, low cost, and stability advantages over live-attenuated vaccines.
  • Based on disease type, the PRRS (Porcine Reproductive and Respiratory Syndrome) led the market with the largest revenue share of 14.26% in 2024.
  • Based on route of administration, the injectable segment led the market with the largest revenue share of 75.79% in 2024, due to its efficiency and effectiveness in providing long-lasting protection against major diseases in pigs.
  • Based on distribution channel, the hospital/clinic pharmacies segment accounted for the largest revenue share in 2024, due to their direct engagement with end-users, immediate vaccination services, and comprehensive healthcare solutions, ensuring timely vaccine distribution and effective disease management in the livestock sector.
  • North America dominated the swine vaccines market with the largest revenue share of 38.46% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Disease Type
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Swine Vaccines Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising concern about zoonoses & strengthening biosecurity
      • 3.2.1.2. Vaccines act as an alternative to antibiotics
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Supply bans on live pigs and pork products
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Political Landscape
      • 3.3.3.1. Economic Landscape
      • 3.3.3.2. Social Landscape
      • 3.3.3.3. Technology Landscape
      • 3.3.3.4. Legal Landscape
      • 3.3.3.5. Environmental Landscape
      • 3.3.3.6. Regulatory Landscape
    • 3.3.4. Product Pipeline Analysis
    • 3.3.5. Covid-19 Analysis
    • 3.3.6. Estimated Pig population by key countries, 2018 to 2024

Chapter 4. Swine Vaccines Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Modified/Attenuated Live
    • 4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Inactivated (Killed)
    • 4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Swine Vaccines Market: Disease Type Business Analysis

  • 5.1. Disease Type Market Share, 2024 & 2030
  • 5.2. Disease Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2018 to 2030 (USD Million)
  • 5.4. Swine Influenza
    • 5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Classical Swine Fever
    • 5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Porcine Parvovirus
    • 5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Porcine Circovirus Type 2
    • 5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. M.Hyo
    • 5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Actinobacillus Pleuropneumonia
    • 5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. PRRS
    • 5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.11. Foot & Mouth Disease
    • 5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.12. Pseudorabies
    • 5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.13. PEDV
    • 5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Swine Vaccines Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Injectables
    • 6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Intranasal
    • 6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Oral
    • 6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Swine Vaccines Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2024 & 2030
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 7.4. Retail
    • 7.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. E-commerce
    • 7.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Hospital/Clinic Pharmacies
    • 7.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Swine Vaccines Market: Regional Estimates & Trend Analysis by Product, Disease Type, Route of Administration, and Distribution Channel

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. U.S. swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Canada swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Mexico swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. UK swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Germany swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. France swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Italy swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Spain swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Norway swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Denmark swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Sweden swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Japan swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. China swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. India swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. South Korea swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Australia swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Thailand swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Brazil swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Argentina swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. South Africa swine vaccines market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Merck & Co., Inc.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Ceva
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Zoetis
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Boehringer Ingelheim GmbH
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Elanco
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Indian Immunologicals Ltd.
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. BiogenesisBago
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Phibro Animal Health
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. KM Biologics
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. HIPRA
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Virbac
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives

Chapter 10. Key Takeaways